Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
G patch domain-containing protein 1 (GPATCH1) is a highly conserved RNA-binding protein distinguished by its N-terminal G-patch domain, which interacts with spliceosomal proteins and RNA[1][3]. GPATCH1 serves as a regulatory cofactor for the DEAH-box RNA helicase DHX35, anchoring it to the active spliceosome and facilitating proper pre-mRNA splicing quality control by suppressing aberrant splicing events[1]. Structural and functional studies demonstrate that GPATCH1 interacts with core spliceosome components (notably PRP8), recognizes suboptimal splice sites, and helps maintain splicing fidelity across eukaryotes from yeast to humans[1][2]. There are currently no known drugs or targeted therapies acting directly on GPATCH1, nor is it established as a classical therapeutic target or disease biomarker.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on G patch domain-containing protein 1 (GPATCH1).